These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 206462)

  • 1. Increased cyclic AMP-independent protein kinase activity in thyroid toxic adenomas.
    Munari Y; Orgiazzi J; Mornex R
    FEBS Lett; 1978 Apr; 88(2):211-4. PubMed ID: 206462
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of an histone kinase activity specifically found in hyperfunctioning benign thyroid tumors.
    Munari-Silem Y; Orgiazzi J; Rostagnat A; Mornex R
    Biochimie; 1981 Jun; 63(6):527-33. PubMed ID: 6266516
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of different protein kinase activities in the human thyroid gland. Evidence for an abnormal form in hyperfunctioning adenomas.
    Munari-Silem Y; Orgiazzi J; Mornex R
    Biochem Biophys Res Commun; 1979 Aug; 89(4):1314-21. PubMed ID: 227383
    [No Abstract]   [Full Text] [Related]  

  • 4. The adenylate cyclase-cyclic AMP-phosphodiesterase system in pathological human thyroid.
    Macchia V; Mandato E; Carella C; Pisano G; Biscaglia G
    J Endocrinol Invest; 1978 Oct; 1(4):337-45. PubMed ID: 229151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human thyroid cyclic nucleotide phosphodiesterase. Its characterization and the effect of several hormones on the activity.
    Nagasaka A; Hidaka H
    Biochim Biophys Acta; 1976 Jul; 438(2):449-60. PubMed ID: 182233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP-dependent protein kinase activation in hearts from euthyroid and hyperthyroid rats.
    Katz S; Hamilton D; Tenner T; McNeill JH
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):777-80. PubMed ID: 200995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine 3',5'-cyclic-monophosphate dependent protein kinase and cyclic-AMP-binding in human mammary tumors.
    Eppenberger U; Talmadge K; Küng W; Bechtel E; Preisz J; Huber P; Jungmann RA; Salokangas A
    FEBS Lett; 1977 Aug; 80(1):229-34. PubMed ID: 196926
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein kinase C activity in human thyroid carcinoma and adenoma.
    Hatada T; Sakanoue Y; Kusunoki M; Kobayashi A; Utsunomiya J
    Cancer; 1992 Dec; 70(12):2918-22. PubMed ID: 1451074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine 3':5'-cyclic monophosphate-dependence of protein kinase isoenzymes from mouse liver.
    Ueland PM; Doskeland SO
    Biochem J; 1976 Jul; 157(1):117-26. PubMed ID: 183739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic 3',5'-nucleotide phosphodiesterase activities in the thyroid glands of patients with various disorders.
    Nagasaka A; Hidaka H
    J Clin Endocrinol Metab; 1980 Apr; 50(4):726-33. PubMed ID: 6245100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-dependent protein kinase type I and type II and cyclic AMP binding in human mammary tumors.
    Eppenberger U; Biedermann K; Handschin JC; Fabbro D; Küng W; Huber PR; Roos W
    Adv Cyclic Nucleotide Res; 1980; 12():123-8. PubMed ID: 6250347
    [No Abstract]   [Full Text] [Related]  

  • 12. Subcellular distribution of cyclic AMP-dependent protein phosphotransferases in horse thyroid gland.
    Sand G; Verhaegen M
    Arch Int Physiol Biochim; 1972 Dec; 80(5):984-5. PubMed ID: 4127098
    [No Abstract]   [Full Text] [Related]  

  • 13. Alteration in cyclic AMP-dependent protein kinases and polyamine biosynthetic enzymes during hypertrophy and hyperplasia of the thyroid in the rat.
    Combest WL; Russell DH
    Mol Pharmacol; 1983 May; 23(3):641-7. PubMed ID: 6306431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The activity of nonspecific phosphatases of the thyroid gland in diffuse toxic goiter and thyrotoxic adenoma].
    Liul'ka AN; Shust IV
    Probl Endokrinol (Mosk); 1969; 15(2):27-32. PubMed ID: 4308922
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble cyclic AMP-dependent protein kinases from chick kidney. Effects of dilution and non-protein inhibitors.
    Jones GM; Mac Neil S; Martin TJ
    Biochim Biophys Acta; 1979 Feb; 582(3):504-14. PubMed ID: 217442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on a cyclic AMP-dependent protein kinase from rat thyroid gland.
    Leonard JL; Rosenberg LL
    Biochim Biophys Acta; 1977 Oct; 484(2):336-47. PubMed ID: 199261
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of calf-ovary adenosine;3':5'-monophosphate-dependent protein kinases and adenosine-3':5'-monophosphate-binding proteins.
    Talmadge DW; Bechtel E; Salonkangas A; Huber P; Jungmann RA; Eppenberger U
    Eur J Biochem; 1975 Dec; 60(2):621-32. PubMed ID: 173547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone increases type I adenosine 3', 5'-monophosphate-dependent protein kinase and casein kinase activities in rat liver cytosol: analysis of protein kinases by polyacrylamide disc gel electrophoresis.
    Nakamura H; Rue PA; DeGroot LJ
    Endocrinology; 1983 Apr; 112(4):1427-33. PubMed ID: 6299694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
    Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
    Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcellular distribution of protein kinases stimulated by cyclic AMP and cyclic AMP receptor proteins in the swine thyroid].
    Roques M; Tirard A; Torresani J
    Biochimie; 1973; 55(11):1421-30. PubMed ID: 4364377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.